Back to December 2009: Updates from the 2009 San Antonio Breast Cancer Symposium
Clinical trials for gamma-secretase inhibitors and breast cancer stem cells?
- Question from DJ: There was some exciting news about targeting breast cancer stem cells. My oncologist calls this the "holy grail." Any indication as to when trials may be open for "gamma-secretase inhibitors"?
- Answer —Kathy Miller, M.D. : The data on gamma-secretase inhibitors did look exciting, but it's important to remember this is early data in laboratory and animal models. It frequently takes several years to move those ideas into the clinic with the very first clinical trials. This is not an agent that I've had any experience with, so I don't know specifically how close they are to activating the first trial.